Justin D. Gover, Chief Executive Officer at GW PHARMACEUTICALS PLC (GWPH), sold 194,184 shares at $10.02 ($1.9M) on 2020-11-16, disclosed to the SEC on 2020-11-17.
Open-market sale of $1.9M GWPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.01 | 42,984 | $430K | 22.1% |
| 2 | $10.01 | 42,984 | $430K | 22.1% |
| 3 | $10.02 | 22,800 | $228K | 11.7% |
| 4 | $10.03 | 42,708 | $428K | 22.0% |
| 5 | $10.03 | 42,708 | $428K | 22.0% |
| Total | $10.02 avg | 194,184 |
| $1.9M |
| 100% |
| Filing → |
| GWPH | SELL | 2020-02-28 | $194K | — | Filing → |
| GWPH | SELL | 2020-02-05 | $3.9M | — | Filing → |
| GWPH | SELL | 2019-12-19 | $49K | — | Filing → |